Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Preclinical study of CD19 detection methods post tafasitamab treatment.
Front Immunol. 2023 Oct 20;14:1274556. doi: 10.3389/fimmu.2023.1274556. eCollection 2023.
Front Immunol. 2023.
PMID: 37928552
Free PMC article.
Tafasitamab mediates killing of B-cell non-Hodgkin's lymphoma in combination with γδ T cell or allogeneic NK cell therapy.
Her JH, Pretscher D, Patra-Kneuer M, Schanzer J, Cho SY, Hwang YK, Hoeres T, Boxhammer R, Heitmueller C, Wilhelm M, Steidl S, Endell J.
Her JH, et al. Among authors: boxhammer r.
Cancer Immunol Immunother. 2022 Nov;71(11):2829-2836. doi: 10.1007/s00262-022-03165-w. Epub 2022 Mar 29.
Cancer Immunol Immunother. 2022.
PMID: 35348812
Free PMC article.
Item in Clipboard
Safety, tolerability, and efficacy of monoclonal CD38 antibody felzartamab in late antibody-mediated renal allograft rejection: study protocol for a phase 2 trial.
Mayer KA, Budde K, Halloran PF, Doberer K, Rostaing L, Eskandary F, Christamentl A, Wahrmann M, Regele H, Schranz S, Ely S, Firbas C, Schörgenhofer C, Kainz A, Loupy A, Härtle S, Boxhammer R, Jilma B, Böhmig GA.
Mayer KA, et al. Among authors: boxhammer r.
Trials. 2022 Apr 8;23(1):270. doi: 10.1186/s13063-022-06198-9.
Trials. 2022.
PMID: 35395951
Free PMC article.
Item in Clipboard
α-Radioimmunotherapy with ²¹³Bi-anti-CD38 immunoconjugates is effective in a mouse model of human multiple myeloma.
Teiluf K, Seidl C, Blechert B, Gaertner FC, Gilbertz KP, Fernandez V, Bassermann F, Endell J, Boxhammer R, Leclair S, Vallon M, Aichler M, Feuchtinger A, Bruchertseifer F, Morgenstern A, Essler M.
Teiluf K, et al. Among authors: boxhammer r.
Oncotarget. 2015 Mar 10;6(7):4692-703. doi: 10.18632/oncotarget.2986.
Oncotarget. 2015.
PMID: 25576914
Free PMC article.
Item in Clipboard
Lenalidomide enhances MOR202-dependent macrophage-mediated effector functions via the vitamin D pathway.
Busch L, Mougiakakos D, Büttner-Herold M, Müller MJ, Volmer DA, Bach C, Fabri M, Bittenbring JT, Neumann F, Boxhammer R, Nolting J, Bisht S, Böttcher M, Jitschin S, Hoffmann MH, Balzer H, Beier F, Gezer D, Dudziak D, Gelse K, Hennig FF, Pallasch CP, Spriewald B, Mackensen A, Bruns H.
Busch L, et al. Among authors: boxhammer r.
Leukemia. 2018 Nov;32(11):2445-2458. doi: 10.1038/s41375-018-0114-0. Epub 2018 Mar 28.
Leukemia. 2018.
PMID: 29654274
Item in Clipboard
Immunologic Responses After COVID-19 Vaccination in Patients With Membranous Nephropathy Receiving Anti-CD38 Felzartamab Therapy: Results From the Phase 1b/2a M-PLACE Study.
Rovin BH, Boxhammer R, Thakur A, Ronco PM.
Rovin BH, et al. Among authors: boxhammer r.
Kidney Int Rep. 2022 Sep;7(9):2086-2090. doi: 10.1016/j.ekir.2022.05.031. Epub 2022 Jun 10.
Kidney Int Rep. 2022.
PMID: 35702397
Free PMC article.
No abstract available.
Item in Clipboard
A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection.
Mayer KA, Schrezenmeier E, Diebold M, Halloran PF, Schatzl M, Schranz S, Haindl S, Kasbohm S, Kainz A, Eskandary F, Doberer K, Patel UD, Dudani JS, Regele H, Kozakowski N, Kläger J, Boxhammer R, Amann K, Puchhammer-Stöckl E, Vietzen H, Beck J, Schütz E, Akifova A, Firbas C, Gilbert HN, Osmanodja B, Halleck F, Jilma B, Budde K, Böhmig GA.
Mayer KA, et al. Among authors: boxhammer r.
N Engl J Med. 2024 May 25. doi: 10.1056/NEJMoa2400763. Online ahead of print.
N Engl J Med. 2024.
PMID: 38804514
Item in Clipboard
Fully human antibodies against the Protease-Activated Receptor-2 (PAR-2) with anti-inflammatory activity.
Giblin P, Boxhammer R, Desai S, Kroe-Barrett R, Hansen G, Ksiazek J, Panzenbeck M, Ralph K, Schwartz R, Zimmitti C, Pracht C, Miller S, Magram J, Litzenburger T.
Giblin P, et al. Among authors: boxhammer r.
Hum Antibodies. 2011;20(3-4):83-94. doi: 10.3233/HAB-2011-0243.
Hum Antibodies. 2011.
PMID: 22129678
Item in Clipboard
Cite
Cite